↓ Skip to main content

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status

Overview of attention for article published in BMC Cancer, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
Published in
BMC Cancer, March 2015
DOI 10.1186/s12885-015-1186-0
Pubmed ID
Authors

Martina Broecker-Preuss, Stefan Müller, Martin Britten, Karl Worm, Kurt Werner Schmid, Klaus Mann, Dagmar Fuhrer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Portugal 1 2%
Unknown 39 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 22%
Student > Bachelor 4 10%
Student > Ph. D. Student 4 10%
Student > Master 4 10%
Student > Postgraduate 3 7%
Other 6 15%
Unknown 11 27%
Readers by discipline Count As %
Medicine and Dentistry 9 22%
Biochemistry, Genetics and Molecular Biology 8 20%
Agricultural and Biological Sciences 5 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Nursing and Health Professions 1 2%
Other 1 2%
Unknown 14 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2022.
All research outputs
#4,804,273
of 23,206,358 outputs
Outputs from BMC Cancer
#1,242
of 8,417 outputs
Outputs of similar age
#60,207
of 264,192 outputs
Outputs of similar age from BMC Cancer
#36
of 247 outputs
Altmetric has tracked 23,206,358 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,417 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,192 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 247 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.